Consolidated Financial Statement Detail (Tables)

12 Months Ended

Dec. 31, 2014

Consolidated Financial Statement Detail [Abstract]

Receivables

Receivables consisted of the following at December 31, 2014 and 2013 (in thousands):

	December 31,
	2014		2013
Trade receivables, net	$	2,993	$	3,731
Other receivables		316		50
Total	$	3,309	$	3,781

Property and equipment

Property and equipment consisted of the following at December 31, 2014 and 2013 (in thousands):

	December 31,
	2014			2013
Equipment and furniture	$	28,638		$	28,365
Buildings, leasehold and building improvements		9,343			9,316
Construction-in-progress		337			225
Land		310			310
		38,628			38,216
Less:  Accumulated depreciation and amortization		(33,508	)		(31,760	)
Property and equipment, net	$	5,120		$	6,456

Accrued liabilities

Accrued liabilities consisted of the following at December 31, 2014 and 2013 (in thousands):

	December 31,
	2014		2013
Incentive compensation	$	4,295	$	4,386
Accrued payroll and other benefits		3,061		3,009
Accrued clinical trial costs		1,424		878
Other		1,112		1,661
Total	$	9,892	$	9,934